Skip Navigation LinksHome > October 2013 - Volume 19 - Issue 11 > Effects of Retinoids in Mouse Models of Colitis: Benefit or...
Inflammatory Bowel Diseases:
doi: 10.1097/MIB.0b013e31829cf1fc
Original Basic Science Articles

Effects of Retinoids in Mouse Models of Colitis: Benefit or Danger to the Gastrointestinal Tract?

Frey-Wagner, Isabelle PhD; Fischbeck, Anne PhD; Cee, Alexandra MSc; Leonardi, Irina MSc; Gruber, Sven; Becker, Eugenia MSc; Atrott, Kirstin; Lang, Silvia; Rogler, Gerhard MD, PhD

Supplemental Author Material
Collapse Box

Abstract

Background:

In vitro and in vivo data have shown that retinoid treatment promotes an anti-inflammatory milieu with few adverse effects toward the gastrointestinal tract. The in vivo studies reported here further evaluate retinoid effects in 2 mouse models of inflammatory bowel disease.

Method:

Chronic dextran sulfate sodium colitis was induced in age- and weight-matched C57Bl/6 mice by 4 cycles of dextran sulfate sodium administration (6–8 animals/group). At cycle 4, animals were administered 13-cis-retinoic acid (isotretinoin, 30 mg/kg) or vehicle (oral gavage) or 4-oxo-13-cis-retinoic acid (15 mg/kg, intraperitoneal) daily. T-cell transfer colitis was induced in CB17 SCID mice by transfer of naive CD4+CD62L+ T cells and treated by transfer of regulatory CD4+CD25+ T cells (4–6 animals/group); isolated from BALB/c mice after treatment with isotretinoin or vehicle, as above, for 2 weeks. Assessments included endoscopic and histological scores, myeloperoxidase activity, serum cytokines, and plasma isotretinoin levels.

Results:

Retinoid-treated animals with colitis showed comparable changes in myeloperoxidase activity, and endoscopic and histological scores, versus untreated animals with colitis. Modest and comparable changes were seen in body weight and colon length in animals injected with naive T cells from isotretinoin-treated donors versus those injected with T cells from vehicle-treated donors. Retinoid treatment was consistently associated with lower interleukin-12 levels, which, after the transfer of naive T cells from isotretinoin-treated donors, supported isotretinoin-mediated predisposition of naive T cells toward reduced proinflammatory cytokine expression. Colitis had no effect on isotretinoin exposure.

Conclusions:

Retinoids attenuate the proinflammatory cytokine response in vivo, with only modest effects on body weight and parameters of gastrointestinal morphology.

Copyright © 2013 Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.